These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 25454907)

  • 1. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
    Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction.
    Palazzo F; Rosato EL; Chaudhary A; Evans NR; Sendecki JA; Keith S; Chojnacki KA; Yeo CJ; Berger AC
    J Am Coll Surg; 2015 Apr; 220(4):672-9. PubMed ID: 25667145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts.
    Tam V; Luketich JD; Winger DG; Sarkaria IS; Levy RM; Christie NA; Awais O; Shende MR; Nason KS
    Ann Thorac Surg; 2016 Nov; 102(5):1638-1646. PubMed ID: 27353482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival After Esophagectomy: A Propensity-Matched Study of Different Surgical Approaches.
    Weksler B; Sullivan JL
    Ann Thorac Surg; 2017 Oct; 104(4):1138-1146. PubMed ID: 28760463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimally Invasive Esophagectomy Provides Equivalent Survival to Open Esophagectomy: An Analysis of the National Cancer Database.
    Mitzman B; Lutfi W; Wang CH; Krantz S; Howington JA; Kim KW
    Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):244-253. PubMed ID: 28823338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma.
    Singh RK; Pham TH; Diggs BS; Perkins S; Hunter JG
    Arch Surg; 2011 Jun; 146(6):711-4. PubMed ID: 21690448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open versus minimally invasive esophagectomy: clinical outcomes for locally advanced esophageal adenocarcinoma.
    Kauppi J; Räsänen J; Sihvo E; Huuhtanen R; Nelskylä K; Salo J
    Surg Endosc; 2015 Sep; 29(9):2614-9. PubMed ID: 25480610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Recurrence and Long-Term Survival of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Locally Advanced Esophageal Cancer Treated with Neoadjuvant Chemotherapy: a Propensity Score-Matched Analysis.
    Sugimura K; Miyata H; Kanemura T; Takeoka T; Sugase T; Masuzawa T; Katsuyama S; Motoori M; Takeda Y; Murata K; Yano M
    J Gastrointest Surg; 2023 Jun; 27(6):1055-1065. PubMed ID: 36749557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes following minimally invasive and open esophagectomy in Finland: A population-based study.
    Sihvo E; Helminen O; Gunn J; Sipilä JOT; Rautava P; Kytö V
    Eur J Surg Oncol; 2019 Jun; 45(6):1099-1104. PubMed ID: 30553631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
    Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
    Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
    Franko J; Voynov G; Goldman CD
    Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective comparison of totally minimally invasive versus open Ivor Lewis esophagectomy.
    Noble F; Kelly JJ; Bailey IS; Byrne JP; Underwood TJ;
    Dis Esophagus; 2013 Apr; 26(3):263-71. PubMed ID: 23551569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of comorbidity on outcomes and overall survival after open and minimally invasive esophagectomy for locally advanced esophageal cancer.
    Dolan JP; Kaur T; Diggs BS; Luna RA; Schipper PH; Tieu BH; Sheppard BC; Hunter JG
    Surg Endosc; 2013 Nov; 27(11):4094-103. PubMed ID: 23846365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.